Chen et al. have recently found that LIPUS treatment mitigates LPS-induced memory impairment, repression of inflammation as well as BDNF decline in an Alzheimer’s disease animal model via the modulation of TLR4/NF-κB signaling and CREB/BDNF expression [19]. The gene discussed is CREB1; the disease is Alzheimer disease.